Phase II trial of S-1 as second-line therapy in patients with advanced non-small cell lung cancer

Ramaswamy Govindan, Daniel Morgensztern, Michael D. Kommor, Roy S. Herbst, Paul Schaefer, Jitendra Gandhi, Kaku Saito, Christopher Zergebel, Joan Schiller

Research output: Contribution to journalArticlepeer-review

19 Scopus citations

Fingerprint

Dive into the research topics of 'Phase II trial of S-1 as second-line therapy in patients with advanced non-small cell lung cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences